Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
Recruiting · NCT05401110 · Registry updated 2026-08-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2026-08-06 | NCT05401110 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Enviro Therapeutics, Inc. | 1 |
| Karen Reckamp, MD, MS | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars-Sinai Cancer at Beverly Hills (THO) | Beverly Hills | United States | 2 |
| Cedars-Sinai Cancer at Hunt Cancer Center - TMPNCC | Torrance | United States | 1 |
| Cedars-Sinai Cancer at SOCC | Los Angeles | United States | 3 |
| Cedars-Sinai Cancer at The Angeles Clinic and Research Institute | Los Angeles | United States | 1 |
| Cedars-Sinai Medical Center | Los Angeles | United States | 392 |